CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 116 enrolled
Drug / intervention
Insulin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05752929
NCT05752929Phase 4Completed
CompareCT.gov

Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients in an Institution in Bogotá, Colombia

Hospital Universitario Clinica San Rafael·interventional·Posted Mar 3, 2023·Updated Mar 3, 2023

In Brief

A Phase 4 clinical trial evaluating Insulin and insulin for Diabete Type 2 and Hyperglycemia. Completed, enrolled 116 participants.

Detailed Summary

Hyperglycemia in the hospital is associated with multiple adverse outcomes. Previously, the mobile insulin scheme was used for its control. However, in the last decade, several studies have shown that the insulin basal-bolus (basal plus) regimen is associated with better glycemic control and a lower risk of hypoglycemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabete Type 2, Hyperglycemia
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 3, 2023
Enrollment StartJan 1, 2016
Primary CompletionDec 31, 2018
Study CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 3.3 years ago

Interventions

Insulindrug

correction scheme with Rapid Acting Insulin Analogs according with the Umpierrez sensitive correction scheme

insulindrug

correction scheme with Rapid Acting Insulin Analogs according with the Davidson correction scheme